Literature DB >> 28779285

Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).

Jorge Romero1, Michael Grushko1, David F Briceño1, Andrea Natale2, Luigi Di Biase3.   

Abstract

PURPOSE OF REVIEW: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable form of cardiomyopathy, typically with autosomal dominant transmission, shown to be a defect in the cardiac desmosomes, with distinct regional and histopathological features. Clinically, this can ultimately result in bi-ventricular failure and/or malignant ventricular tachycardia (VT) via reentrant circuits created by patchy scar formation. We sought to review the current treatment for ventricular arrhythmias in the setting of ARVC, with particular attention to radiofrequency (RF) ablation and its varied techniques, along with potential therapies in the ablation spectrum. RECENT
FINDINGS: There is underwhelming data on the effectiveness of medical therapy for ARVC-related VT, including beta-blockers and antiarrhythmic medication. Primary and secondary prophylactic implantable-cardioverter defibrillator (ICD) implantation in higher-risk patients is recommended. More recently, RF ablation has been used for ARVC-related VT. Endocardial VT ablation in this setting can produce acute success, though recurrence rate is quite high, which may be explained by the more epicardial and patchy nature of the disease. Combined endocardial-epicardial ablation has since been shown to be feasible, safe, and with significantly better acute and long-term success, particularly when combined with scar dechanneling or homogenization of the scar. However, recurrence rates are not insignificant, and ablation does not eliminate the need for ICD placement. Medical therapy for ARVC-related VT is suboptimal. RF ablation techniques including endocardial and epicardial approaches appear to have the highest success rates for ARVC-related VT. Catheter ablation of VT in ARVC patients should be considered a potentially effective strategy for eliminating frequent VT episodes and ICD shocks rather than a curative therapeutic approach, until long-term efficacy has been consistently documented. Research into the optimal mapping and ablation techniques are promising and ongoing.

Entities:  

Keywords:  ARVD; Cardiomyopathy; Catheter ablation; Epicardial access; ICD; Ventricular tachycardia

Mesh:

Substances:

Year:  2017        PMID: 28779285     DOI: 10.1007/s11886-017-0893-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  38 in total

1.  Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.

Authors:  Aditya Bhonsale; Cynthia A James; Crystal Tichnell; Brittney Murray; Dmitri Gagarin; Binu Philips; Darshan Dalal; Ryan Tedford; Stuart D Russell; Theodore Abraham; Harikrishna Tandri; Daniel P Judge; Hugh Calkins
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

2.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2008-05-15       Impact factor: 29.690

Review 3.  Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Domenico Corrado; Mark S Link; Hugh Calkins
Journal:  N Engl J Med       Date:  2017-01-05       Impact factor: 91.245

4.  Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Binu Philips; Anneline S J M te Riele; Abhishek Sawant; Vishnupriya Kareddy; Cynthia A James; Brittney Murray; Crystal Tichnell; Bina Kassamali; Saman Nazarian; Daniel P Judge; Hugh Calkins; Harikrishna Tandri
Journal:  Heart Rhythm       Date:  2014-12-18       Impact factor: 6.343

5.  Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Glenn M Polin; Haris Haqqani; Wendy Tzou; Mathew D Hutchinson; Fermin C Garcia; David J Callans; Erica S Zado; Francis E Marchlinski
Journal:  Heart Rhythm       Date:  2010-11-27       Impact factor: 6.343

6.  Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Domenico Corrado; Loira Leoni; Mark S Link; Paolo Della Bella; Fiorenzo Gaita; Antonio Curnis; Jorge Uriarte Salerno; Diran Igidbashian; Antonio Raviele; Marcello Disertori; Gabriele Zanotto; Roberto Verlato; Giuseppe Vergara; Pietro Delise; Pietro Turrini; Cristina Basso; Franco Naccarella; Francesco Maddalena; N A Mark Estes; Gianfranco Buja; Gaetano Thiene
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

7.  Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Darshan Dalal; Rahul Jain; Harikrishna Tandri; Jun Dong; Shaker M Eid; Kalpana Prakasa; Crystal Tichnell; Cynthia James; Theodore Abraham; Stuart D Russell; Sunil Sinha; Daniel P Judge; David A Bluemke; Joseph E Marine; Hugh Calkins
Journal:  J Am Coll Cardiol       Date:  2007-07-16       Impact factor: 24.094

8.  Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia.

Authors:  K E Ellison; P L Friedman; L I Ganz; W G Stevenson
Journal:  J Am Coll Cardiol       Date:  1998-09       Impact factor: 24.094

9.  Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Pasquale Santangeli; Erica S Zado; Gregory E Supple; Haris M Haqqani; Fermin C Garcia; Cory M Tschabrunn; David J Callans; David Lin; Sanjay Dixit; Mathew D Hutchinson; Michael P Riley; Francis E Marchlinski
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-11-06

10.  Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/D): A Systematic Literature Review.

Authors:  Jorge Romero; Eliany Mejia-Lopez; Carlos Manrique; Richard Lucariello
Journal:  Clin Med Insights Cardiol       Date:  2013-05-21
View more
  6 in total

Review 1.  Cardiac Sympathetic Denervation for the Management of Ventricular Arrhythmias.

Authors:  Stephanie M Kochav; Hasan Garan; Lyall A Gorenstein; Elaine Y Wan; Hirad Yarmohammadi
Journal:  J Interv Card Electrophysiol       Date:  2022-04-09       Impact factor: 1.900

2.  For Whom the Bell Tolls : Refining Risk Assessment for Sudden Cardiac Death.

Authors:  Ivaylo Tonchev; David Luria; David Orenstein; Chaim Lotan; Yitschak Biton
Journal:  Curr Cardiol Rep       Date:  2019-08-02       Impact factor: 2.931

3.  Right ventricular free-wall scar: an exceptional source of post-infarction ventricular tachycardia. A case report.

Authors:  Massimo Tritto; Elvira Renzullo; Domenico Zagari; Paolo Moretti
Journal:  Eur Heart J Case Rep       Date:  2019-06-01

4.  Ablation strategies for arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis.

Authors:  Li-Shui Shen; Li-Min Liu; Li-Hui Zheng; Feng Hu; Zhi-Cheng Hu; Shang-Yu Liu; Jin-Rui Guo; Kush Kumar Bhagat; Yan Yao
Journal:  J Geriatr Cardiol       Date:  2020-11-28       Impact factor: 3.327

Review 5.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) in clinical practice.

Authors:  Ka Hou Christien Li; George Bazoukis; Tong Liu; Guangping Li; William K K Wu; Sunny Hei Wong; Wing Tak Wong; Yat Sun Chan; Martin C S Wong; Katharina Wassilew; Vassilios S Vassiliou; Gary Tse
Journal:  J Arrhythm       Date:  2017-12-21

6.  My approach to ventricular tachycardia ablation in patient with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Xavier Waintraub; Estelle Gandjbakhch
Journal:  HeartRhythm Case Rep       Date:  2020-02-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.